210 related articles for article (PubMed ID: 28420072)
1. Reduction of nitric oxide and DNA/RNA oxidation products are associated with active disease in systemic lupus erythematosus patients.
Iriyoda TMV; Stadtlober N; Lozovoy MAB; Delongui F; Costa NT; Reiche EMV; Dichi I; Simão ANC
Lupus; 2017 Sep; 26(10):1106-1111. PubMed ID: 28420072
[TBL] [Abstract][Full Text] [Related]
2. Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift.
Scavuzzi BM; Simão ANC; Iriyoda TMV; Lozovoy MAB; Stadtlober NP; Franchi Santos LFDR; Flauzino T; de Medeiros FA; de Sá MC; Consentin L; Reiche EMV; Maes M; Dichi I
Immunol Res; 2018 Feb; 66(1):158-171. PubMed ID: 29185130
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus.
Lozovoy MA; Simão AN; Panis C; Rotter MA; Reiche EM; Morimoto HK; Lavado E; Cecchini R; Dichi I
Lupus; 2011 Oct; 20(12):1250-9. PubMed ID: 21813592
[TBL] [Abstract][Full Text] [Related]
4. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Wang G; Pierangeli SS; Papalardo E; Ansari GA; Khan MF
Arthritis Rheum; 2010 Jul; 62(7):2064-72. PubMed ID: 20201076
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
6. Oxidative and nitrosative stress biomarkers in chronic schizophrenia.
Boll KM; Noto C; Bonifácio KL; Bortolasci CC; Gadelha A; Bressan RA; Barbosa DS; Maes M; Moreira EG
Psychiatry Res; 2017 Jul; 253():43-48. PubMed ID: 28346888
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
Costa NT; Scavuzzi BM; Iriyoda TMV; Lozovoy MAB; Alfieri DF; de Medeiros FA; de Sá MC; Micheletti PL; Sekiguchi BA; Reiche EMV; Maes M; Simão ANC; Dichi I
Clin Exp Med; 2018 Aug; 18(3):363-372. PubMed ID: 29644482
[TBL] [Abstract][Full Text] [Related]
8. Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life.
Gomes C; Martinho FC; Barbosa DS; Antunes LS; Póvoa HCC; Baltus THL; Morelli NR; Vargas HO; Nunes SOV; Anderson G; Maes M
Mol Neurobiol; 2018 Apr; 55(4):2814-2827. PubMed ID: 28455694
[TBL] [Abstract][Full Text] [Related]
9. Relationship between iron metabolism, oxidative stress, and insulin resistance in patients with systemic lupus erythematosus.
Lozovoy MA; Simão AN; Oliveira SR; Iryioda TM; Panis C; Cecchini R; Dichi I
Scand J Rheumatol; 2013; 42(4):303-10. PubMed ID: 23424997
[TBL] [Abstract][Full Text] [Related]
10. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
[TBL] [Abstract][Full Text] [Related]
11. Alternations of salivary antioxidant enzymes in systemic lupus erythematosus.
Zaieni SH; Derakhshan Z; Sariri R
Lupus; 2015 Nov; 24(13):1400-5. PubMed ID: 26113360
[TBL] [Abstract][Full Text] [Related]
12. Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby.
Roomruangwong C; Barbosa DS; Matsumoto AK; Nogueira AS; Kanchanatawan B; Sirivichayakul S; Carvalho AF; Duleu S; Geffard M; Moreira EG; Maes M
J Affect Disord; 2017 Dec; 223():49-58. PubMed ID: 28719808
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.
Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Kallaur AP; Mezzaroba L; Lozovoy MAB; Sabino BS; Ferreira KPZ; Pereira WLCJ; Kaimen-Maciel DR; Dichi I; Reiche EMV
J Neurol Sci; 2017 Oct; 381():213-219. PubMed ID: 28991684
[TBL] [Abstract][Full Text] [Related]
14. Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis.
Ferreira KPZ; Oliveira SR; Kallaur AP; Kaimen-Maciel DR; Lozovoy MAB; de Almeida ERD; Morimoto HK; Mezzaroba L; Dichi I; Reiche EMV; Simão ANC
J Neurol Sci; 2017 Feb; 373():236-241. PubMed ID: 28131195
[TBL] [Abstract][Full Text] [Related]
15. Hypertension is associated with serologically active disease in patients with systemic lupus erythematosus: role of increased Th1/Th2 ratio and oxidative stress.
Lozovoy MA; Simão AN; Morimoto HK; Iryioda TM; Panis C; Reiche EM; Borelli SD; Oliveira SR; Cecchini R; Dichi I
Scand J Rheumatol; 2014; 43(1):59-62. PubMed ID: 24134304
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin (LL-37) and its correlation with pro-oxidant, antioxidant balance and disease activity in systemic lupus erythematosus: a cross-sectional human study.
Sahebari M; Roshandel G; Saadati N; Saghafi M; Abdolahi N; Rezaieyazdi Z
Lupus; 2017 Aug; 26(9):975-982. PubMed ID: 28420069
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
Lozovoy MA; Simão AN; Hohmann MS; Simão TN; Barbosa DS; Morimoto HK; Reiche EM; Cecchini R; Dichi I
Lupus; 2011 Nov; 20(13):1356-64. PubMed ID: 21868433
[TBL] [Abstract][Full Text] [Related]
18. Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities.
Maes M; Supasitthumrong T; Limotai C; Michelin AP; Matsumoto AK; de Oliveira Semão L; de Lima Pedrão JV; Moreira EG; Carvalho AF; Sirivichayakul S; Barbosa DS; Kanchanatawan B
Mol Neurobiol; 2020 Aug; 57(8):3334-3348. PubMed ID: 32514863
[TBL] [Abstract][Full Text] [Related]
19. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study.
Sincer İ; Kurtoğlu E; Yılmaz Çoşkun F; Aktürk S; Vuruşkan E; Düzen İV; Saraçoğlu E; Aktürk E; Hidayet Ş
Anatol J Cardiol; 2015 Nov; 15(11):913-8. PubMed ID: 25868041
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
